Introduction {#s1}
============

The staphylococci are a diverse group of Gram-positive, catalase-positive facultative anaerobes, consisting of approximately 36 species hosted largely by the human body (Kloos and Bannerman, [@B65]). Historically, the staphylococci have been broadly divided into two groups based on their coagulase activity with *Staphylococcus aureus* representing the most notable, coagulase-positive pathogen of the genus. *S. aureus* is often regarded as the leading cause of infections of the bloodstream, skin, soft tissue, and lower respiratory system (Moet et al., [@B85]). In contrast, coagulase-negative staphylococci (CoNS) were largely considered to be harmless commensals of the skin and mucous membranes until recent years, when the opportunistically pathogenic *S. epidermidis* has emerged as the most frequent cause of device-associated nosocomial infections (reviewed in Otto, [@B96]). The appearance of vancomycin-resistance in clinical isolates of both *S. aureus* and CoNS, in addition to the increasing prevalence of community-associated methicillin-resistant *S. aureus* (CA-MRSA), highlights the continued need to develop novel strategies to combat these global pathogens (Srinivasan et al., [@B125]; Vandenesch et al., [@B140]).

The success of the staphylococci has been attributed, in part, to their ability to acquire iron from the host. In contrast to its relative abundance in nature, iron represents a severely growth-limiting nutrient *in vivo*. Indeed, while the solubility for ferric iron is often cited as 10^−18^ M, an adjusted calculation suggests that the actual concentration is closer to 10^−9^--10^−10^ M at neutral pH in aerobic environments, based on Fe(OH)^+^~2~ being the primary species instead of Fe(OH)~3~ (Ratledge and Dover, [@B106]). The revised value is still orders of magnitude lower than required to support microbial growth and additionally, iron within the host is further sequestered in glycoproteins such as transferrin and lactoferrin, bound within storage proteins such as ferritin and hemosiderin, or complexed with heme in the form of hemoglobin and myoglobin (Ratledge, [@B105]). Sequestration of iron functions both in preventing the catalysis of reactions generating damaging free radicals and in providing nutritional immunity against bacterial infection (Schaible and Kaufmann, [@B109]).

To circumvent the aforementioned restrictions, the staphylococci have evolved a plethora of mechanisms to acquire iron from the host, including the elaboration of multiple siderophores, utilization of xenosiderophores, acquisition of iron from heme and hemoproteins, and the uptake of inorganic free iron (Beasley and Heinrichs, [@B9]; Haley and Skaar, [@B48]; Hammer and Skaar, [@B49]). Each of these systems employs an iron-regulated membrane protein, almost always of the *A*TP-*b*inding *c*assette (ABC) transporter superfamily, for import of iron or complexed-iron across the membrane. In addition to the required ABC-type membrane permease and ATPase (Davidson et al., [@B32]), these iron-regulated ABC transporters employ a high-affinity membrane-anchored lipoprotein, i.e., a protein bearing an N-terminal, covalently linked lipid (Hutchings et al., [@B62]), for the specific recognition and binding of the iron substrate; these lipoproteins are analogous to the periplasmic substrate binding proteins (SBPs) of Gram-negative bacteria. Acylation of the hydrophilic protein promotes localization of the lipid into the phospholipid bilayer, anchoring the protein in close proximity to the membrane where it is positioned, once bound by substrate, to interact with its cognate ABC transporter to facilitate translocation of substrate into the cell. Whereas many other functions have been attributed to lipoproteins in bacteria, including sensing and signaling, protein secretion, antibiotic resistance, adhesion and the uptake of many nutrients in addition to iron (Sutcliffe and Russell, [@B130]), herein we focus attention solely on the iron-regulated lipoproteins (IRLPs) expressed by the staphylococci, given their important roles in staphylococcal pathogenesis and immune stimulation. Of the approximately 50 total lipoproteins encoded by *S. aureus*, the species in which most of the work has been performed, studies from several laboratories have identified, to date, a total of 9 IRLPs---SirA, HtsA, SstD, FhuD1, FhuD2, IsdE, FepA, SitC, and Opp1A. These proteins will be the subject of this review.

Control of iron-regulated gene expression
=========================================

Fur
---

The *f*erric *u*ptake *r*egulator (Fur) is a homodimeric metalloprotein that functions as a transcriptional regulator of iron homeostasis in many bacteria. When complexed with iron, Fur regulates the transcription of genes by binding a 19-bp inverted repeat sequence (5′-GATAATGATAATCATTATC-3′), known as the Fur box, within the operator/promoter region (Escolar et al., [@B37]; Baichoo and Helmann, [@B6]). The Fur protein mainly functions as a repressor, mediating global suppression of iron-responsive genes in response to iron-replete conditions (Xiong et al., [@B146]; Hantke, [@B50]; Baichoo et al., [@B7]). Among the Fur-repressed genes are those involved in iron acquisition; Fur-boxes controlling expression of staphylococcal IRLPs are shown in Figure [1A](#F1){ref-type="fig"}. Binding of Fur to the Fur box sequences is dependent upon concomitant Fe^2+^ binding to Fur and, together, the competent DNA-binding complex blocks association of RNA polymerase with promoters, thereby inhibiting transcription. Under iron restriction, intracellular Fe^2+^ depletion results in dissociation of Fur from DNA, allowing transcription to proceed.

![***S. aureus* Fur boxes, SirR/MntR box, and IRLP signal peptides. (A)** Fur box sequences within the promoter/operator region of operons encoding the indicated *S. aureus* SBP-encoding gene and the SirR/MntR box located upstream of *sitC/mntC*. **(B)** Signal peptides for the indicated IRLPs, with the lipobox indicated by the box. Nucleotide and protein sequences are all derived from *S. aureus* COL.](fcimb-02-00041-g0001){#F1}

SirR/MntR
---------

The notable exception to Fur regulation of the IRLPs is the *s*taphylococcal *i*ron *t*ransporter, SitABC/MntABC. SitABC and SirR were initially discovered in *S. epidermidis* (Cockayne et al., [@B25]), and in *Bacillus subtilis* where the SitABC and SirR homologues were named MntABCD and MntR, respectively, based on work of Helmann and colleagues in confirming their role in manganese uptake and homeostasis (Que and Helmann, [@B102]; Glasfeld et al., [@B41]; Lee and Helmann, [@B71]). The homologous region in *S. aureus* was likewise identified and referred to as MntABC and MntR (Horsburgh et al., [@B61]). Expression of *sitABC*/*mntABC* is controlled by the diphtheria toxin repressor (DtxR)-like homologue, SirR/MntR (Hill et al., [@B58]; Horsburgh et al., [@B61]; Ando et al., [@B3]). Transcription of *sitABC* is repressed by SirR in the presence of either Mn^2+^ or Fe^2+^ in *S. epidermidis* (Hill et al., [@B58]), although there is some contention over whether both Mn^2+^ or Fe^2+^, or just Mn^2+^ controls expression in *S. aureus* (Horsburgh et al., [@B61]; Ando et al., [@B3]). Like with Fur, transcription is blocked in the presence of these divalent metal ions because the metal ions facilitate the binding of SirR/MntR to a conserved SirR (or MntR) box (Figure [1A](#F1){ref-type="fig"}), a region of dyad symmetry in the promoter/operator region of *sitABC/mntABC* (Hill et al., [@B58]; Ando et al., [@B3]). Repression of transcription is relieved when the metal ion concentration is depleted.

Lipoprotein biogenesis
======================

A detailed and comprehensive analysis of lipoprotein biogenesis is outside the scope of this review, but we refer the reader to a recent review, and references therein, for an excellent summary of lipoprotein biogenesis in bacterial pathogens (Kovacs-Simon et al., [@B67]). Bacterial preprolipoproteins bear both an N-terminal signal peptide, characteristic of secreted proteins, and, within the C-region of the signal peptide, a conserved sequence \[L/V/I\]~−3~−\[A/S/T/V/I\]~−2~−\[G/A/S\]~−1~−C~+1~ which is referred to as the lipobox motif (see Figure [1B](#F1){ref-type="fig"} for lipobox motif of *S. aureus* IRLPs) (Kovacs-Simon et al., [@B67]). In the first biogenesis reaction, the lipoprotein diacylglyceryl transferase (Lgt) covalently links a diacylglycerol moiety to the thiol group on the side chain of the essential +1 cysteine of the lipobox. The subsequent reaction involves the cleavage of the signal peptide from the diacylated prolipoprotein by lipoprotein signal peptidase (Lsp; alternatively called signal peptidase II), an activity that appears contingent upon lipidation by Lgt in Gram-negative bacteria (Tokunaga et al., [@B137]), but is not a prerequisite in Gram-positive bacteria (Baumgartner et al., [@B8]). In a third reaction, highly conserved among Gram-negative bacteria and the Actinomycetes, the enzyme lipoprotein *N*-acyl transferase (Lnt) catalyzes the addition of a third fatty acid to the free amino group of the cysteine, resulting in a triacylated protein. With few exceptions, the *lgt*, *lsp*, and *lnt* genes are indispensible in Gram-negative bacteria, yet in contrast, these genes are dispensable in Gram-positive bacteria (reviewed in Kovacs-Simon et al., [@B67]).

Given the apparent lack of *lnt* homologues within Firmicute genomes, it was presumed that lipoproteins within this phylum were diacylated, a notion supported by the identification of diacylated lipoproteins among the staphylococci (Tawaratsumida et al., [@B135]). In contradistinction, SitC (MntC), the predominant lipoprotein of *S. aureus* and SBP for SitABC (MntABC), was found to be triacylated in multiple *S. aureus* strains and in *S. epidermidis* (Kurokawa et al., [@B69]; Asanuma et al., [@B5]). Furthermore, four other major staphylococcal lipoproteins were found to be triacylated (Asanuma et al., [@B5]), including the same lipoprotein earlier identified to be diacylated by Tawaratsumida et al. ([@B135]). The discrepancies between these studies could be attributed to differences in culture conditions and preparation of the lipoproteins, given that Asanuma et al. noted a minor presence of diacylated SitC (MntC) lipopeptides in cultures grown at elevated temperatures (Asanuma et al., [@B5]). The notion of global *N*-acylation among the Firmicutes is further bolstered by a recent report of triacylated lipoproteins among the class Mollicute in *Acholeplasma laidlawii*, despite the lack of a recognizable Lnt homolog in this bacterium (Serebryakova et al., [@B118]). Consequently, the nature by, and degree to which, staphylococcal lipoproteins are *N*-acylated remains unknown, and it is possible that an as-yet unidentified enzyme, with no similarity to Gram-negative Lnt enzymes, exists within the Firmicutes that is responsible for this elusive activity.

The staphylococcal IRLPs: functions in iron acquisition
=======================================================

The thus-far identified nine IRLPs in the staphylococci are involved in, or at least implicated in, the uptake of iron through either siderophore (Figure [2A](#F2){ref-type="fig"}) or non-siderophore (Figure [2B](#F2){ref-type="fig"}) based systems. Together, these systems engender staphylococci with versatility in that they are able to recognize and utilize a broad range of iron substrates. Unsurprisingly, the common function of these IRLP is reflected in their largely conserved overall protein structure.

![**Iron acquisition systems in *S. aureus*. (A)** Siderophore-dependent iron uptake systems. **(B)** Siderophore-independent iron uptake systems. Each system is discussed in the text. The open reading frame accession number, based on *S. aureus* COL genome, for each of the IRLPs (blue) is indicated. The directionality indicated for each of the genes is as in the genome. The red star represents heme and the open star represents protoporphyrin IX. Hb, hemoglobin; Hp, haptoglobin.](fcimb-02-00041-g0002){#F2}

As a result of a recent revisitation of the classification scheme to segregate SBPs based upon structural characteristics (Berntsson et al., [@B13]), the majority of the staphylococcal IRLPs, with the exception of FepA and Opp1A (discussed below), fall into cluster A, which consists of class III SBPs associated with ABC transporters. These proteins have an approximately 20 residue long α-helical backbone that joins two independently folded domains, each of which consists of central β-strands surrounded by α-helices; substrate is bound into the groove formed between the two domains (Figure [3A](#F3){ref-type="fig"}). Relative to members of other SBP clusters, hinge motion, upon binding of the substrate, between the two domains of cluster A proteins is restricted by the helical spine. Docking of the cluster A SBPs with their cognate membrane ABC-type permeases is facilitated by salt-bridges formed between conserved glutamic acid residues on the lobes of the SBP (Figure [3A](#F3){ref-type="fig"}) and patches of positive charge on the exterior surface of the permease, formed by three conserved arginine/lysine residues (Borths et al., [@B16]).

![**Representative structure of cluster A SBPs, and structures of protein-bound Fe-SA and Fe-SB. (A)** Representative ribbon diagram to highlight some of the key characteristics of the cluster A SBPs, including the helical spine (yellow) connecting the alpha/beta N-terminal (blue) and C-terminal (red) lobes that surround the binding pocket (green triangle), and the two conserved glutamic acid residues (black) that interact with the membrane permease. **(B)** Structure of iron-bound staphyloferrin A with coordinating residues from the *S. aureus* HtsA SBP (PDB 3LI2). **(C)** Structure of iron-bound staphyloferrin B with coordinating residues from the *S. aureus* SirA SBP (PDB 3MWF).](fcimb-02-00041-g0003){#F3}

HtsA and SirA---receptors for the ferrated staphyloferrin siderophores
----------------------------------------------------------------------

Siderophores are secreted, low-molecular-weight molecules that have high-affinity for ferric iron. Among members of the staphylococci, two siderophores may be produced, staphyloferrin A (SA) and staphyloferrin B (SB) (Konetschny-Rapp et al., [@B66]; Meiwes et al., [@B82]; Drechsel et al., [@B34]; Haag et al., [@B47]). Enzymes for the synthesis of SA and SB are encoded from the *sfaABCD* and *sbnABCDEFGHI* loci, respectively (Dale et al., [@B29],[@B30]; Beasley et al., [@B11]; Cheung et al., [@B21]; Cotton et al., [@B26]) (Figure [2A](#F2){ref-type="fig"}). Adjacent to each of these biosynthetic loci, but transcribed separately, are operons encoding the requisite ABC-transporters for uptake of Fe-SA and Fe-SB complexes (Dale et al., [@B29],[@B30]; Beasley et al., [@B11], [@B10]; Beasley and Heinrichs, [@B9]). The transport systems for the two siderophores have been shown to be non-interchangeable, where HtsABC specifically uptakes Fe-SA and SirABC specifically uptakes Fe-SB (Beasley et al., [@B11]). While each of the transporter-encoding operons codes for a SBP (HtsA and SirA) and a heterodimeric permease component (HtsBC and SirBC), both lack a gene encoding the ATPase component of the ABC transporter. Instead, at least in *S. aureus*, FhuC, expressed from the *fhuCBG* operon (Figure [2A](#F2){ref-type="fig"}) serves as the ATPase for import of both Fe-SA and Fe-SB (Speziali et al., [@B124]; Beasley et al., [@B11]). The notion of a common ATPase between multiple iron acquisition pathways is not unprecedented; the YusV ATPase in *B. subtilis* acts in the uptake of siderophores through both *feuABC* and *yfiYZyfhA* (Ollinger et al., [@B94]). Currently available genomic sequences reveal that while the *hts-sfa* locus is found in all staphylococcal genomes (incl. *S. aureus*, *S. epidermidis*, *S. lugdunensis*, *S. saprophyticus*, *S. haemolyticus*, *S. pseudintermedius*, *S. warneri*, *S. capitis*, *S. caprae*, *S. hominis*, *S. carnosus* and *S. xylosus*), the *sir-sbn* locus is only found in the genomes of *S. aureus* and *S. pseudintermedius*. Curiously, however, SB was identified in the supernatants of several members of CoNS, and was first identified in coagulase-variable *S. hyicus* (Konetschny-Rapp et al., [@B66]; Meiwes et al., [@B82]; Drechsel et al., [@B34]); the reason for the discrepancy between these findings and the available genome information remains unknown. Genomes of *S. lugdunensis*, although possessing *htsABC*, carry a deletion of *sfaA* and *sfaD*, suggesting that this species may utilize Fe-SA as an iron source, but likely does not synthesize either staphyloferrin molecule.

Given that both SA and SB are highly hydrophilic, α-hydroxycarboxylate type siderophores (Beasley and Heinrichs, [@B9]), highly specific binding to their cognate receptors would be necessary to maintain the aforementioned uptake specificity. Without the specific recognition and binding of Fe-SA and Fe-SB to HtsA and SirA, respectively, one might anticipate that transporters for these structurally similar siderophores would be interchangeable. Recent structural characterizations of both HtsA and SirA have shed significant light on the reason for this specificity. HtsA and SirA both adopt the bilobed, α-helical backboned structure typical of the cluster A SBPs (see above), and their binding pockets are shallow and basic to accommodate the negatively charged siderophores, yet few residues within the substrate binding pocket are conserved between the two lipoproteins (Grigg et al., [@B42],[@B43]). HtsA coordinates Fe-SA through H-bonding between six arginine residues, directed into the binding pocket, and oxygen atoms in SA (Figure [3B](#F3){ref-type="fig"}) (Grigg et al., [@B43]). Conserved residue R125 also anchors Fe-SB in SirA (Grigg et al., [@B42]), however the remaining coordinating residues are unique (Figure [3C](#F3){ref-type="fig"}). The number of coordinating arginine residues is a reflection of the net negative charge on the associated siderophore, where up to six are required to neutralize the --5 net charge on SA, and three are required for the --3 net charge of SB. Furthermore, while siderophore binding to HtsA and SirA induces negligible hinge movement along the α-helix, significant and specific conformational changes occur within the C-terminal domain of both (Grigg et al., [@B42],[@B43]). The unique coordinating residues, in addition to the distinct conformational changes, likely maintain the specificity and affinity of these receptors for their cognate siderophores, and it is unsurprising that their ligand affinities fall within the nanomolar range (Grigg et al., [@B42],[@B43])

Inactivation of any of the individual biosynthetic or transport loci for SA or SB yields an unimpressive, if any, phenotype when examining for defects in iron-restricted growth (Beasley et al., [@B11], [@B10]). However, the combined inactivation of either *sbn* together with *sfa* or *sir* together with *hts* yields mutants with severe growth defects in serum (Beasley et al., [@B11], [@B10]). Notably, the inactivation of multiple transport systems in *S. aureus* results in decreased bacterial fitness during infection, relative to inactivation of the corresponding biosynthetic loci (Beasley et al., [@B10]), likely due to the continued production of siderophores even in the absence of their cognate receptors, which would enhance iron-starvation *in vivo* (Beasley et al., [@B10]). Impairment of receptor function, therefore, represents a potential avenue for therapeutic intervention (see below).

SstD---receptor for ferrated catechols/catecholamines
-----------------------------------------------------

Catechol siderophores, typified by the well-studied enterobactin (or enterochelin), bacillibactin, vibriobactin and salmochelin, are representative of a major class of bacterial siderophores (for a review, see Miethke and Marahiel, [@B83]). Additionally, the ability of catecholamine stress hormones to stimulate growth of bacteria, including members of CoNS, in the presence of serum (i.e., transferrin) has been studied over the past decade (Freestone et al., [@B39], [@B40]; Neal et al., [@B93]). Indeed, recent work illuminated how hormones such as epinephrine and norepinephrine are capable of reducing transferrin-bound ferric iron to ferrous iron and thereby liberating iron from this central component of innate immunity (Sandrini et al., [@B108]). While catechol siderophores have not been identified in culture supernatants of staphylococci, staphylococci are capable of using both catechols and catecholamines as an iron source via the SstABCD ABC transporter (Beasley et al., [@B10]). The locus (Figure [2A](#F2){ref-type="fig"}), initially identified through screens for iron-regulated staphylococcal antigens (Morrissey et al., [@B88]), is highly conserved among *S. aureus* strains and present in the majority of CoNS. The function of this transporter remained uncharacterized until recently, when *sst* mutations were characterized in staphyloferrin-deficient strains (Beasley et al., [@B10]). The *sst* locus is required for growth promotion by catechol siderophores and catecholamine-liberated transferrin iron, and contributes to *in vivo* colonization of the murine liver and kidneys. With the exception of the colonization of murine hearts, these *in vivo* and *in vitro* effects were otherwise masked in strains synthesizing the staphyloferrins (Beasley et al., [@B10]).

SstD specifically binds both ferrated catechol siderophores and catecholamine stress hormones with micromolar and submicromolar affinities (Beasley et al., [@B10]). The reduced affinity of SstD for its ligands, relative to SirA and HtsA, is likely a trade-off in favor of an enhanced range of potential substrates. The closest homologs to SstD include the YclQ protein from *B. subtilis* and the CeuE protein from *Campylobacter jejuni.* Structural information exists for these proteins in complex with their ligands; YclQ binds the "stealth" siderophore petrobactin (Zawadzka et al., [@B149]), while CeuE binds iron complexed by the enterobactin analog, mecam (Muller et al., [@B89]). Some conservation in the binding mechanism of these proteins is indicated by shared binding pocket residues between SstD, CeuE, and YclQ, which in CeuE interact with the mecam substrate. Crystallographic information for liganded SstD unfortunately remains lacking, but this information would afford insight into the mechanism by which this receptor binds a diverse range of catechol ligands.

FhuD1 and FhuD2---receptors for ferric-hydroxamate siderophores
---------------------------------------------------------------

While the staphylococci have not been demonstrated to synthesize hydroxamate-type siderophores, they are known to be able to utilize them as iron sources. These include aerobactin (produced by some enterobacteriaceae), ferrichrome (produced by the basidiomycete fungus *Ustilago sphaerogena*), coprogen (produced by *Neurospora crassa*), and desferrioxamine B, produced by *Streptomyces pilosus*; the mesylate salt of desferrioxamine B is used clinically under the name Desferal™ (Brock and Ng, [@B17]; Sebulsky et al., [@B115]; Sebulsky and Heinrichs, [@B114]). Uptake of multiple hydroxamate-type siderophores was similarly demonstrated for *B. subtilis* (Schneider and Hantke, [@B112]), and a homologous system identified in the *S. aureus* (Sebulsky et al., [@B115]). Ferric-hydroxamate uptake is achieved through the concerted effort of the FhuC ATPase, FhuBG heterodimeric permease, and the independently transcribed substrate-binding lipoproteins, FhuD1 and FhuD2 (Figure [2A](#F2){ref-type="fig"}) (Sebulsky et al., [@B115]; Sebulsky and Heinrichs, [@B114]). All species of staphylococci, with the possible exception of *S. hominis* and *S. xylosus*, possess the Fhu uptake system.

While many hydroxamate ligands are common between FhuD1 and FhuD2, the two lipoproteins do possess some unique substrate specificities with FhuD2 exhibiting both a wider range of ligands and greater substrate affinity than FhuD1 (Sebulsky et al., [@B116], [@B117]). While FhuD1 appears to be a less effective Fe^3+^-siderophore SBP than FhuD2, it is certainly possible that the substrates and/or conditions under which FhuD1 are optimal are not defined. While the structures of FhuD1 and FhuD2 are not yet available, structures have been determined for *E. coli* FhuD bound to several hydroxamate ligands (Clarke et al., [@B24], [@B23]). In contrast to the binding pocket of proteins such as SirA and HtsA, which harbor key charged residues that interact with the siderophore molecule, the structures of *E. coli* FhuD show that the binding of ligands is largely dependent upon hydrophobic contacts; accommodation of several different hydroxamate substrates occurs only through subtle rearrangements of the FhuD protein side-chains.

IsdE---a heme receptor
----------------------

*isdE* homologues have been identified in several Gram-positive pathogens including *S. aureus*, *S. lugdunensis, Bacillus anthracis, Clostridium tetani*, and *Listeria monocytogenes* (Skaar and Schneewind, [@B122]; Heilbronner et al., [@B56]). The *i*ron-regulated *s*urface *d*eterminant pathway (Isd) represents the predominant system for iron acquisition from heme and hemoproteins in *S. aureus* (Mazmanian et al., [@B78], [@B77]). The proposed architectural arrangement of the nine Isd proteins, facilitated by anchoring to the cell wall through sortase A activity (for IsdA, IsdB, and IsdH), and *isd* locus-encoded sortase B activity (for IsdC), allows for heme, extracted from hemoglobin or haptoglobin-hemoglobin, at the cell surface to be shuttled proximal to the membrane where it is bound by the SBP IsdE, and transported into the cytoplasm through the ABC permease IsdF (Figure [2B](#F2){ref-type="fig"}) (Mazmanian et al., [@B77]; Skaar and Schneewind, [@B122]; Torres et al., [@B138]; Muryoi et al., [@B91]; Zhu et al., [@B150]; Grigg et al., [@B44]). Once in the cytoplasm, heme may be degraded by IsdG and IsdI, releasing iron (Skaar et al., [@B120],[@B121]; Lee et al., [@B72]).

As a member of the cluster A SBPs (see above), IsdE possesses the characteristics depicted in Figure [3A](#F3){ref-type="fig"} but, unlike SirA and HtsA, bears a deep hydrophobic groove between the two lobes comprising a heme binding pocket (Grigg et al., [@B45]). A single intermediate or high-spin ferric or, preferentially, low-spin ferrous heme molecule is coordinated by the axial ligands H229 and M78 (Grigg et al., [@B45]; Pluym et al., [@B100]). As with several of the other iron ABC transporters in the staphylococci, the *isdEF* genes are not genetically linked with a gene encoding the obligatory ATPase for the transporter. It is possible that the promiscuous FhuC drives transport through IsdEF.

*In vitro* experiments using purified proteins demonstrated that IsdE could receive heme directly from IsdC (depicted in Figure [2B](#F2){ref-type="fig"}), as part of a larger study that provided support to the notion that the Isd proteins act together as a heme shuttle system within the bacterial cell wall and membrane (Muryoi et al., [@B91]). Moreover, growth impairment has been demonstrated for Isd mutants cultured on hemoglobin as a sole iron source (Torres et al., [@B138]; Pishchany et al., [@B98], [@B99]); subsequent to hemoglobin binding at the cell surface and heme extraction, heme is likely never free from a protein and is shuttled through the wall and membrane via direct Isd-Isd protein contacts. On the contrary, it should be noted, that an *isdE* mutation had less of an impact when cultured in the presence of heme as a sole iron source (Grigg et al., [@B45]). The lack of a marked phenotype for the *isdE* mutant on heme raises the likely possibility that when presented with free heme, a growth-supporting amount of heme makes its way through the cell wall, bypassing the Isd proteins, and is taken into the cell via non-specific mechanisms or by secondary heme transporters, a notion currently under investigation.

FepA---an iron receptor
-----------------------

The translocation of staphylococcal preprolipoproteins was initially thought to occur exclusively through the dominant secretory pathway, Sec (Driessen and Nouwen, [@B35]; Natale et al., [@B92]). However, the *t*win-*a*rginine *t*ranslocation pathway (Tat) is another means of lipoprotein translocation across the membrane in a number of Gram-positive, high GC bacteria (McDonough et al., [@B79]; Widdick et al., [@B142], [@B143]; Thompson et al., [@B136]), and was recently identified in some (incl. *S. aureus*, *S. haemolyticus* and *S. carnosus*), but not all, staphylococcal genomes. Pre-folded proteins bearing a twin arginine motif in their signal peptide are secreted by Tat (Meissner et al., [@B81]; Biswas et al., [@B14]), however the role of Tat in the staphylococci appears limited both in the apparent lack of complete Tat homologues in many CoNS, such as *S. epidermidis* and *S. saprophyticus*, and in identified substrates (Yamada et al., [@B148]; Biswas et al., [@B14]). Currently, the sole identified substrate of Tat is the iron-dependent DyP-family peroxidase, FepB (Biswas et al., [@B14]).

Dye-decolorizing (DyP)-type peroxidases form a unique heme peroxidase family (for a review, see Sugano, [@B129]), and members of the family have been reported to have several different substrates (Letoffe et al., [@B75]; Ahmad et al., [@B1]; Liers et al., [@B76]). Insofar as iron uptake is concerned, two Dyp paralogs in *E. coli*, namely YfeX and EfeB (cytoplasmic and periplasmic enzymes, respectively), were reported to have deferrochelatase activity on heme (Letoffe et al., [@B75]). Deferrochelation would provide bacteria with an iron source in the absence of dedicated heme uptake systems, however this is currently a subject of some debate. A recent study has argued that the *E. coli* YfeX protein is not a heme deferrochelatase but rather is a peroxidase that oxidizes porphyrinogens to porphyrins (Dailey et al., [@B28]). Should DyP-type peroxidases bear deferrochelatase activity, it is possible that, like YfeX and EfeB, staphylococcal FepB could also serve to release ferrous iron from heme.

In addition to FepB, the *fepABC* operon, located adjacent to *tatAC*, encodes an iron permease (FepC) and a putative iron-binding lipoprotein (FepA) (Figure [2B](#F2){ref-type="fig"}). The exact function of *S. aureus fepABC* in iron acquisition is still under investigation, and the substrate specificity of FepA has not yet been determined. Free ferrous iron released through the potential deferrocheletase activity of FepB could serve as a substrate for FepAC, similar to *E. coli* ferrous iron-specific *efeUOB*, which has been shown to be induced by growth in aerobic, low pH and low iron conditions (Grosse et al., [@B46]; Cao et al., [@B19]). Alternatively, *fepABC* may function in elemental iron uptake in a manner analogous to the Ftr1p/Fet3p ferric iron permease in *Saccharomyces cerevisiae*, where Fe^2+^ is oxidized to Fe^3+^ by the multicopper oxidase, Fet3p, and is subsequently transported into the cell by Ftr1p (Kwok et al., [@B70]). A similar mechanism was first proposed in *B. subtilis* for *ywbLMN*, a *fepABC* homologue, and, accordingly, the *ywbLMN* operon was shown essential to the normal growth of *B. subtilis* in iron-restricted media (Ollinger et al., [@B94]; van der Ploeg et al., [@B139]). Regardless, the presence of *fep* operon homologs in many different bacteria, including both Gram-positive and Gram-negative species, suggests a conserved and important functionality. Indeed, *S. aureus fep-tat* mutants are impaired in inorganic iron uptake and virulence in a murine renal abscess model (Biswas et al., [@B14]).

Although no structure of a staphylococcal FepA protein has yet been solved, homology searches and structural modeling indicate that it is rather unique among the IRLPs. The closest homologs to FepA are members of the imelysin-like superfamily (Xu et al., [@B147]). The canonical imelysin fold is all-helical, comprising two similar four-helix bundle domains with a predicted functional site at the domain interface (Xu et al., [@B147]). Specifically, a conserved GxHxxE motif, also present in staphylococcal FepA proteins, is located at the open end of the binding cleft; this motif has been implicated in the coordination of divalent metal cations (Rajasekaran et al., [@B103],[@B104]; Xu et al., [@B147]). With well over 100 members, the imelysin-like proteins are widely distributed in bacteria and are virtually always located next to a gene encoding a DyP-type peroxidase. Although biochemical evidence is still lacking, this reinforces the assumption that the FepABC-like systems are involved in iron uptake, where the peroxidase potentially converts ferrous iron to ferric iron, which is the ligand for the FepA-like binding proteins.

Opp1A
-----

Despite being annotated as an oligopeptide permease, *opp1ABCDF* has no defined role in nitrogen metabolism (Hiron et al., [@B59]). However, Opp1A, the SBP of this complex, was shown to be significantly upregulated during iron-starvation, both by our laboratory (unpublished data) and others (Hempel et al., [@B57]), consistent with the identification of a putative Fur box upstream of Opp1A (Figure [1A](#F1){ref-type="fig"}). The role of oligopeptide permeases in metal ion and heme acquisition is not unprecedented; *S. aureus* Opp2BCDF and the orphan SBP Opp5A were recently renamed NikBCDE and NikA due to their role in nickel acquisition (Hiron et al., [@B60]), whereas in *E. coli* a di-peptide permease is involved in the uptake of both nickel and heme (DppA) (Letoffe et al., [@B73], [@B74]; Shepherd et al., [@B119]). A potential role for Opp1A in iron acquisition is currently under investigation.

The *opp1ABCDF* operon encodes a prototypical oligopeptide permease: two homologous permease proteins (OppB and OppC) and two ATP-binding proteins (OppD and OppF), in addition to the peptide/SBP (Figure [2B](#F2){ref-type="fig"}). Like FepA, Opp1A is not a member of the cluster A SBPs, but instead is a member of cluster C which includes oligopeptide, di-peptide and nickel binding proteins (Berntsson et al., [@B13]). Cluster C members are characterized by a larger size (approx. 50--70 kDa) than the cluster A proteins (which are typically in the 30--35 kDa range), a large binding cavity, an extra domain that augments the binding cavity - in some cases to accommodate larger peptide ligands, and ligand binding via a "Venus flytrap" mechanism (Berntsson et al., [@B12], [@B13]). The latter point indicates that these proteins capture their substrates through significant inter-domain hinge movement, unlike the relative lack of inter-domain movement afforded by the helical spine of the cluster A SBPs (see above).

According to Hiron et al. (Hiron et al., [@B59]), *S. aureus* possesses two additional oligopeptide permeases (*opp3* and *opp4*) and one di/tri-peptide permease (*dtpT*), in addition to *opp1* and *nikA/nikBCDE*. While *opp3* and *dtpT* are involved in nitrogen metabolism (Hiron et al., [@B59]; Borezee-Durant et al., [@B15]), the roles of *opp1* and *opp4* are unknown and none of the lipoproteins have been investigated to determine if, like *E. coli* NikA, they are capable of binding multiple substrates. Although the role of *opp1* is unknown, it has been implicated, along with *opp2* and *dtpT*, in staphylococcal infectivity and survival through signature tagged-mutagenesis studies (Mei et al., [@B80]; Coulter et al., [@B27]). The exact mechanism by which these permeases contribute to virulence, however, is not known.

SitC/MntC---receptors for iron or manganese
-------------------------------------------

SitC, the lipoprotein component of SitABC (Figure [2B](#F2){ref-type="fig"}), was first described as an immunogenic iron-repressible cytoplasmic membrane protein (IRMP) in *S. epidermidis* (Cockayne et al., [@B25]). The 32-kDa *S. epidermidis* SitC protein was found both to be expressed by *S. epidermidis* and to react strongly with antibodies in pooled human peritoneal dialysate (HPD) (Williams et al., [@B145]; Smith et al., [@B123]; Wilcox et al., [@B144]; Modun et al., [@B84]). HPD, the byproduct of continuous ambulatory peritoneal dialysis (CAPD) for renal failure, represents a severely iron-restricted environment (Wallaeys et al., [@B141]; Williams et al., [@B145]). Expression of SitC by *S. epidermidis* and *S. aureus* isolates known to cause peritonitis in CAPD patients highlighted a potential role for SitC in iron acquisition, and consequently *in vivo* survival of the staphylococci.

Sequence analysis of SitC revealed that it bears homology both to proteins involved in bacterial adhesion as well as to metal binding proteins (Cockayne et al., [@B25]). Two of the closest structural homologs to SitC are cluster A SBPs: the zinc-binding TroA protein from *Treponema pallidum* (PDB 1TOA) and the manganese-binding MntC protein from Synechocystis sp. (PDB 1XVL). Given this, and that SitC is lipid tethered to the cell membrane with distribution throughout the cell wall and minimal surface exposure (Smith et al., [@B123]; Wilcox et al., [@B144]; Cockayne et al., [@B25]), it is unlikely to play a role in bacterial adhesion, although involvement in adhesion has not been conclusively disproven. Greater surface exposure would be expected to promote adhesion, which is seen with the adhesins to which SitC was initially likened, but not for SitC itself (Jenkinson, [@B63]; Sutcliffe et al., [@B131]; Cockayne et al., [@B25]). The relatively porous nature of the cell wall, however, would render SitC accessible to metal cations, such as Fe^2+^, Mn^2+^ or Zn^2+^, as well as to antibodies. Additionally, the extracellular release of lipoproteins during iron starvation, such as SitC, would further contribute to immunogenicity (Cockayne et al., [@B25]). Despite a proposed role in divalent metal uptake, the fact that expression of *sitC* is repressed in the presence of excess Mn^2+^ or Fe^2+^ (Hill et al., [@B58]), and that SitC is highly expressed *in vivo*, the substrate of SitC in *S. epidermidis* remains unknown.

In contrast to *S. epidermidis*, the *sitABC* homologue in *S. aureus* has an identified function in the transport of Mn^2+^, and was consequently named *mntABC* (Horsburgh et al., [@B61]) to reflect this activity, following the nomenclature previously used in *B. subtilis* (Que and Helmann, [@B102]). While the presence of Mn^2+^ facilitates repression of *mntABC* through the DtxR-family regulator, MntR (SirR) (see regulation section, above), the role of iron in *mntABC* expression is still unclear (Horsburgh et al., [@B61]; Ando et al., [@B3]). Furthermore, the structure and characterization of the substrate binding properties of MntC (SitC) have yet to be elucidated. Regardless, with MntC (SitC) being identified as a predominant lipoprotein in *S. aureus* and *S. epidermidis*, and the observation that lipoprotein-deficient mutants are both inhibited in iron-restricted growth and in Toll-like receptor 2 (TLR2) activation in the host, it is not surprising that MntC (SitC) contributes an important role in staphylococcal pathogenesis and survival (Stoll et al., [@B127]; Bubeck Wardenburg et al., [@B18]; Schmaler et al., [@B110], [@B111]; Muller et al., [@B90]).

Roles for IRLPs in immune recognition
-------------------------------------

The recognition of bacterial invaders by the innate immune system occurs through the identification of pathogen-associated molecular patterns (PAMPs) by Toll-like receptors (TLRs). Of the \>10 human TLRs currently identified, TLR2, together with the adapter molecule MyD88, represents the main responsive element to Gram-positive cell wall components and, consequently, staphylococcal infection (Takeuchi et al., [@B133], [@B132],[@B134]). Until recently, the predominant staphylococcal PAMP for induction of TLR2 and a potent inducer of cytokine release was considered to be lipoteichoic acid (LTA) (Schwandner et al., [@B113]; Morath et al., [@B86], [@B87]). However, it has been shown that the LTA fractions in these experiments were likely contaminated by lipoproteins, the implied true stimuli for TLR2-mediated inflammation (Hashimoto et al., [@B54],[@B55], [@B53]). The generation of staphylococcal *lgt* mutants (see biogenesis section, above) has revealed that lipid modification of prelipoproteins is essential to maximal activation of and subsequent NF-κB-dependent cytokine release via TLR2-MyD88, both *in vitro* and *in vivo* (Stoll et al., [@B127]; Bubeck Wardenburg et al., [@B18]; Kurokawa et al., [@B69]; Schmaler et al., [@B110]). Conversely, an LTA-depleted mutant was still capable of inducing TLR2 (Kurokawa et al., [@B69]). Furthermore, highly purified SitC (MntC) co-localized with and induced TLR2 (Kurokawa et al., [@B69]; Muller et al., [@B90]), showing direct evidence of IRLP recognition by the host immune system.

*In vivo* studies have revealed a paradox in the expression of lipoproteins during infection. Of particular note, sublethal challenge of mice with an *lgt* mutant resulted in increased mortality relative to the wild-type infection, suggesting that lipoproteins are required to initiate the host innate immune response (Bubeck Wardenburg et al., [@B18]; Schmaler et al., [@B110], [@B111]). Conversely, the expression of lipoproteins increases bacterial burden during persistent tissue infections, shown to be due to their role in enhancing staphylococcal survival through iron acquisition (Schmaler et al., [@B110], [@B111]). While SitC (MntC) represents the predominant iron-regulated staphylococcal lipoprotein, as previously discussed, *S. aureus* lacking SitC (MntC) can still stimulate TLR2 (Kurokawa et al., [@B69]). Given that staphylococcal lipoproteins involved in the acquisition of iron are highly upregulated during iron starvation and expressed *in vivo* and *in vitro* (Morrissey et al., [@B88]; Sebulsky and Heinrichs, [@B114]; Dale et al., [@B29],[@B30]; Skaar et al., [@B120],[@B121]; Allard et al., [@B2]; Hempel et al., [@B57]), they together likely serve as important PAMPs for TLR2 recognition. Together these results suggest that the elaboration of multiple and sometimes redundant IRLPs may ensure staphylococcal survival in an otherwise inflamed host, providing an intriguing option for the development of potential therapeutics.

Clinical applications
---------------------

Given their cell surface exposure, propensity to be expressed *in vivo* and corresponding immunogenicity, the IRLPs represent a tangible target for staphylococcal vaccine development. Indeed, both Sanofi-Pasteur/Syntiron and Novartis are including IRLPs in pre-clinical multivalent vaccine preparations. A discussion of *S. aureus* vaccine attempts is beyond the scope of this review, so we refer the reader to several excellent, recent reviews on the subject (Otto, [@B95]; Daum and Spellberg, [@B31]; DeDent et al., [@B33]; Patti, [@B97]; Proctor, [@B101]). The focus of published passive and active immunization efforts targeting iron acquisition systems thus far have centered on the Isd cell wall anchored proteins IsdA, IsdB, and IsdH, with promising results in animal models of *S. aureus* infection (Clarke et al., [@B22]; Kuklin et al., [@B68]; Ebert et al., [@B36]; Kim et al., [@B64]; Ster et al., [@B126]; Arlian and Tinker, [@B4]; Daum and Spellberg, [@B31]; DeDent et al., [@B33]; Harro et al., [@B52]). Of the Isd proteins, Merck and Intercell took their single-antigen IsdB vaccine, V710 (Kuklin et al., [@B68]), through phase I clinical trials, demonstrating that the vaccine was immunogenic within 2 weeks of administration and had a good safety profile in humans (Harro et al., [@B51], [@B52]). Phase II/III clinical trials were terminated following a statistical review of the data suggesting that V710 was unlikely to demonstrate a significant benefit to patients (Patti, [@B97]). Many experts in the field are now suggesting that as opposed to a single-antigen vaccine, multivalent strategies, at least in humans, offer the greatest chance for success. In support of this recommendation, IsdA and IsdB, when combined with two additional *S. aureus* surface antigens, offered greater protective immunity, at least in rodent models, than when the animals were immunized with the individual antigens alone (Stranger-Jones et al., [@B128]).

In addition to the challenges in mounting an antibody response against the staphylococci (Foster, [@B38]), the functional redundancy (in terms of supplying a vital iron source to the bacteria) and strain variation in iron-regulated proteins suggests multiple systems should be targeted through a combinatorial vaccine. Indeed, the reduced fitness of *sir hts sst* mutants relative to single or double mutants recommends targeting multiple iron acquisition lipoproteins to inhibit growth (Beasley et al., [@B10]). Moreover, effective antibody-based approaches may require antibodies that inhibit protein function, in addition to, or in lieu of, being opsonic. Certainly, protective anti-IsdA and anti-IsdB antibodies appear to function by inhibiting heme acquisition (Kim et al., [@B64]). Thus, puzzling out the substrate specificities, expression patterns, presence/absence in different strains or species, and relevance, alone or in combination, to *in vivo* growth/infectivity is paramount toward effective use of the IRLPs as therapeutic targets. Aside of vaccine strategies, other avenues do exist for taking advantage of iron acquisition systems for therapeutic intervention. It is possible that knowledge on the substrate specificities, along with detailed structural information, will lead to the use of the uptake systems as portals for toxic "trojan horse" compounds that kill or limit growth of the staphylococci.

Concluding remarks
==================

IRLPs play an essential role in the acquisition of iron, and consequently the *in vivo* survival of the staphylococci. Paradoxically, these lipoproteins are also strongly immunogenic, inducing an inflammatory response through recognition by TLR2-MyD88. A balance, therefore, exists between the surface display of multiple IRLPs and evading immune recognition by the host. Both of these characteristics make IRLPs a good choice of targets for vaccine development, and the formulation of a combinatorial vaccine targeting multiple iron uptake systems has been suggested to maximize efficacy. Further research is required to identify the source of the activity responsible for the N-acylation of staphylococcal lipoproteins. More work should also focus on obtaining high-resolution structural information on each of the proteins discussed here. As iron represents an essential element to survival, the IRLPs remain at the interface of pathogenesis and potential therapeutic control of the often pathogenic staphylococci.
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